Human papillomaviruses (HPVs) are responsible for causing most cervical cancers and also other cancers. Thankfully, safe and highly effective anticancer HPV vaccines have been available for nearly 2 decades, and some countries, notably Australia, are aiming to eliminate cervical cancer by 2035—less than 10 years from now—using HPV vaccines. This study asks an important public health question that pediatricians and parents might also ask: do females who originally received 2 doses of HPV vaccine in elementary school need a third dose in high school? That is, are 2 doses noninferior to 2 + 1 doses?
Recent Posts
- Psychological Mechanisms of Narrative Transportation on Brand Outcomes: A Higher Order Brand Experience Model and Product Type Boundary Conditions
- Negotiating Academic Identity in Dilemmatic Space: An Identity Trajectory of an Early-Career Academic in a Marginal Discipline
- JAMA+ Trials Editor’s Choice for Clinical Trial of 2025 in JAMA Network Open
- Patterns of Outpatient Psychotherapy Among Children With Insurance
- Monitoring Changes in Clinical Trial Primary Outcomes Using Large Language Models